1. Retrograde Ethanol Infusion in the Vein of Marshall
- Author
-
Yuesheng Ling, Harvey R. Chen, Liyun Rao, Jasvinder S. Sidhu, Miguel Valderrábano, and Dirar S. Khoury
- Subjects
medicine.medical_specialty ,Vena Cava, Superior ,medicine.medical_treatment ,Ablation of atrial fibrillation ,Catheter ablation ,Vagotomy ,Coronary Angiography ,Article ,Pulmonary vein ,Cicatrix ,Dogs ,Physiology (medical) ,Internal medicine ,Atrial Fibrillation ,medicine ,Animals ,Humans ,Heart Atria ,Infusions, Intravenous ,Vein ,Coronary sinus ,Ethanol ,business.industry ,Atrial fibrillation ,Phlebography ,medicine.disease ,Coronary Vessels ,Treatment Outcome ,medicine.anatomical_structure ,Anesthesia ,Circulatory system ,Catheter Ablation ,Cardiology ,Feasibility Studies ,Cardiology and Cardiovascular Medicine ,business ,Left Pulmonary Vein - Abstract
Background— The vein of Marshall (VOM) is an attractive target during ablation of atrial fibrillation because of its autonomic innervation, its location anterior to the left pulmonary veins, and its drainage in the coronary sinus. Methods and Results— We studied 17 dogs. A coronary sinus venogram showed a VOM in 13, which was successfully cannulated with an angioplasty wire and balloon. In 5 dogs, electroanatomical maps of the left atrium were performed at baseline and after ethanol infusion in the VOM, which demonstrated a new crescent-shaped scar, extending from the annular left atrium toward the posterior wall and left pulmonary veins. In 4 other dogs, effective refractory periods (ERP) were measured at 3 sites in the left atrium, before and after high-frequency bilateral vagal stimulation. The ERP decreased from 113.6�35.0 to 82.2�25.4 ms ( P P =NS). The abolition of vagal effects was limited to sites near the VOM (ERP, 104�14 versus 98.6�12.2 ms postvagal stimulation; P =NS), as opposed to sites remote to VOM (ERP, 107.2�14.9 versus 78.6�14.7 ms postvagal stimulation; P Conclusions— Ethanol infusion in the VOM achieves significant left atrial tissue ablation, abolishes local vagal responses, and is feasible in humans.
- Published
- 2009
- Full Text
- View/download PDF